Thomas Rowe
Thomas Rowe
Потвърден имейл адрес: cdc.gov
Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness
K Subbarao, A Klimov, J Katz, H Regnery, W Lim, H Hall, M Perdue, ...
science 279 (5349), 393-396, 1998
Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays
T Rowe, RA Abernathy, J Hu-Primmer, WW Thompson, X Lu, W Lim, ...
Journal of clinical microbiology 37 (4), 937-943, 1999
Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine
JJ Treanor, JD Campbell, KM Zangwill, T Rowe, M Wolff
New England Journal of Medicine 354 (13), 1343-1351, 2006
Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza
JF Bermejo-Martin, R Ortiz de Lejarazu, T Pumarola, J Rello, R Almansa, ...
Critical care 13, 1-11, 2009
Comparisons of highly virulent H5N1 influenza A viruses isolated from humans and chickens from Hong Kong
DL Suarez, ML Perdue, N Cox, T Rowe, C Bender, J Huang, DE Swayne
Journal of Virology 72 (8), 6678-6688, 1998
Changes in influenza and other respiratory virus activity during the COVID-19 pandemic—United States, 2020–2021
SJ Olsen
MMWR. Morbidity and mortality weekly report 70, 2021
Pathogenesis of avian influenza A (H5N1) viruses in ferrets
LA Zitzow, T Rowe, T Morken, WJ Shieh, S Zaki, JM Katz
Journal of virology 76 (9), 4420-4429, 2002
Gene expression analysis of host innate immune responses during Lethal H5N1 infection in ferrets
CM Cameron, MJ Cameron, JF Bermejo-Martin, L Ran, L Xu, PV Turner, ...
Journal of virology 82 (22), 11308-11317, 2008
Discovery of ketone-based covalent inhibitors of coronavirus 3CL proteases for the potential therapeutic treatment of COVID-19
RL Hoffman, RS Kania, MA Brothers, JF Davies, RA Ferre, KS Gajiwala, ...
Journal of medicinal chemistry 63 (21), 12725-12747, 2020
Risk of influenza A (H5N1) infection among poultry workers, Hong Kong, 1997–1998
CB Bridges, W Lim, J Hu-Primmer, L Sims, K Fukuda, KH Mak, T Rowe, ...
The Journal of infectious diseases 185 (8), 1005-1010, 2002
Lack of transmission of H5N1 avian–human reassortant influenza viruses in a ferret model
TR Maines, LM Chen, Y Matsuoka, H Chen, T Rowe, J Ortin, A Falcon, ...
Proceedings of the National Academy of Sciences 103 (32), 12121-12126, 2006
Risk of influenza A (H5N1) infection among health care workers exposed to patients with influenza A (H5N1), Hong Kong
CB Bridges, JM Katz, WH Seto, PKS Chan, D Tsang, W Ho, KH Mak, ...
The Journal of infectious diseases 181 (1), 344-348, 2000
Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin
RA Bright, DM Carter, S Daniluk, FR Toapanta, A Ahmad, V Gavrilov, ...
Vaccine 25 (19), 3871-3878, 2007
Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts
JM Katz, W Lim, CB Bridges, T Rowe, J Hu-Primmer, X Lu, RA Abernathy, ...
Journal of Infectious Diseases 180 (6), 1763-1770, 1999
Isolation and characterization of avian influenza viruses, including highly pathogenic H5N1, from poultry in live bird markets in Hanoi, Vietnam, in 2001
DC Nguyen, TM Uyeki, S Jadhao, T Maines, M Shaw, Y Matsuoka, ...
Journal of virology 79 (7), 4201-4212, 2005
Modified M2 proteins produce heterotypic immunity against influenza A virus
AM Frace, AI Klimov, T Rowe, RA Black, JM Katz
Vaccine 17 (18), 2237-2244, 1999
Identification of DNA topoisomerase II as an intracellular target of antitumor epipodophyllotoxins in simian virus 40-infected monkey cells
L Yang, TC Rowe, LF Liu
Cancer Research 45 (11_Part_2), 5872-5876, 1985
Infection of a laboratory worker with simian immunodeficiency virus
RF Khabbaz, W Heneine, JR George, B Parekh, T Rowe, T Woods, ...
New England Journal of Medicine 330 (3), 172-177, 1994
Heterosubtypic Immunity against Human Influenza A Viruses, Including Recently Emerged Avian H5 and H9 Viruses, Induced by FLU–ISCOM Vaccine in Mice Requires both Cytotoxic T …
S Sambhara, A Kurichh, R Miranda, T Tumpey, T Rowe, M Renshaw, ...
Cellular immunology 211 (2), 143-153, 2001
Idiopathic CD4+ T-lymphocytopenia--an analysis of five patients with unexplained opportunistic infections
TJ Spira, BM Jones, J Nicholson, RB Lal, T Rowe, AC Mawle, CB Lauter, ...
New England Journal of Medicine 328 (6), 386-392, 1993
Системата не може да изпълни операцията сега. Опитайте отново по-късно.
Статии 1–20